Member Info for krull

Well It's up 4 fold, so a lot did buy, trouble is, no one likes to buy after a big jump in share price, It's the fear of being spiked, personally I can see big profits in this new PSE test, don't forget about the CiRT test, sales are increasing every month, cash from that is filling the company coffers

Deep Pipeline of Blood Tests Moving Towards Clinical Testing in Large Addressable Markets.

Look at page seven, many blood tests in development

https://d1io3yog0oux5.cloudfront.net/_a8fad265a9fd54b9744ba695aa7257e3/oxfordbiodynamics/db/2553/24445/pdf/Oxford+BioDynamics+plc+August+2023.pdf

EpiSwitch CST is the first and only commercially available blood test to predict COVID-19 severity in ANY adult, independent of COVID-19 status.

Covid news LIVE: Pirola strain spreading in UK - old tests may miss infection warns expert

Thanks Galadriel

Galadriel, any chance you could post a link to the website presentation showing the count is up to 97 for June.

I'm not able to find it. If the growth rate for CiRT test keeps on it's trajectory, it will be bringing in significant amounts of funding. It's not too shabby with 97 tests

Thank you sophie98, I see that now, I'm presuming ASP means Actual Sales Price! $2000-2500 So we are looking at:

97 tests in June at $2250 = 218,250 12 months at that rate = $2,619,000

5085, Iv'e seen the presentation, Iv'e put a link out to it 2 times already, I Know all about the PSE test and how important it will be. I was trying to work out how well our other test is selling

Sophie98, could you elaborate a bit more on that for me please, the list price in the presentation for the test says it is $5500 so how does the reimbursement end up at $2500

Looking at the numbers:

97 tests sold in June at $5500 = $533,500 then times that by 12 months = $6,402,000

Ever herd the saying, they can't see the wood for the trees

Because folk think It's too good to be true! Early days yet, when the numbers start rolling in, they will believe

Thank you Galadriel, very nice, some cash rolling in

Targeting a 100 tests a month: 27 sold in February, 40 in March, 51 in April.

Looking good to have reached the 100 a month target by now, IMO, it will surpasses 100 a month, because the accuracy will make more important as a first go to tool.

EpiSwitch CiRT is 85% accurate, the older version is only 42%

Well worth a Sunday afternoon listen

https://www.youtube.com/watch?v=tv1zufLgtQM&pp=ygUSb3hmb3JkIGJpb2R5bmFtaWNz

That thought of that needle going through the Perineum makes my eyes water, he looks well hung

You really wouldn't want to go through this procedure, for the sake of £750, It's not even as conclusive as the test

https://youtu.be/mDein6ObXj0?t=104

Price is likely to come down when more lab space is required for mass screening.

That's a very important point Tricky, Doctors have a duty of care to provide the best solution for your ailment. In America where litigation is a way of life, Doctors need to be careful not to recommend inferior testing/treatments, Imagine you had prostate cancer and slipped through the net because of old technology, you might have somthing to say about that in a court of law!

Trolls will quickly jump on anything remotely tenuous that could be contrived into doom and gloom

mastur vaiter, what a crok of ****